These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical and immunological evaluation of isocyanate-exposed workers. Park HS, Park JN, Kim JW, Kim SK. J Korean Med Sci; 1992 Jun; 7(2):122-7. PubMed ID: 1326284 [Abstract] [Full Text] [Related]
7. A retrospective study of clinical, physiologic and immunologic changes in workers exposed to toluene diisocyanate. Porter CV, Higgins RL, Scheel LD. Am Ind Hyg Assoc J; 1975 Mar; 36(3):159-68. PubMed ID: 167571 [Abstract] [Full Text] [Related]
8. [The response to a specific bronchial provocation test and the evolution of occupational asthma. A longitudinal study in subjects with toluene diisocyanate-induced asthma]. Marabini A, Brugnami G, Curradi F, Severini C, Siracusa A. Med Lav; 1994 Mar; 85(2):134-41. PubMed ID: 8072441 [Abstract] [Full Text] [Related]
9. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Park HS, Nahm DH. Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254 [Abstract] [Full Text] [Related]
15. [Toluene diisocyanate asthma. 1. Clinico-immunological evaluation]. Kido T, Yamada Y, Teranishi H, Daimon N, Shimizu T. Arerugi; 1983 Feb; 32(2):111-20. PubMed ID: 6311143 [No Abstract] [Full Text] [Related]
16. [Bronchial asthma caused by isocyanate in the internal/external environment]. Rasmussen K, Dahl R. Ugeskr Laeger; 1989 May 08; 151(19):1193-5. PubMed ID: 2544056 [Abstract] [Full Text] [Related]
17. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma. Choi JH, Lee KW, Kim CW, Park CS, Lee HY, Hur GY, Kim SH, Hong CS, Jang AS, Park HS. Int Arch Allergy Immunol; 2009 May 08; 150(2):156-63. PubMed ID: 19439981 [Abstract] [Full Text] [Related]